Jonza v. Teva Pharmaceuticals USA, Inc. et al
| Samantha Jonza |
| Teva Women's Health Inc doing business as Teva Women's Health LLC, TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC., Teva Pharmaceuticals USA Inc, Teva Women's Health LLC, The Cooper Companies, Inc. and Coopersurgical Inc |
| 1:2021cv01695 |
| April 26, 2021 |
| US District Court for the Northern District of Georgia |
| Leigh Martin May |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 26, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 13
ORDER INITIAL CONFERENCE: The Court held its Initial Conference in this MDL on February 9, 2021. The below are the orders entered after discussion of these issues at that conference. 1. Leadership structure: After the Court discussed issues concerning the leadership structure with all parties, the Court ORDERED Plaintiffs and Defendants to each file their proposed consent motion and order as to their requested leadership structure and team within 7 days of the date of this order. 2. Future status conferences: The Court will hold status conferences once a month. The next six conferences will take place on the following dates at 10:00 am via zoom: Tuesday, March 9, 2021; Monday, April 12, 2021; Wednesday, May 12, 2021; Monday, June 14, 2021; Tuesday, July 13, 2021; Friday, August 20, 2021. The Court will send out the zoom links prior to the conferences. The parties will submit a proposed consent agenda 3 business days prior to the conference. The parties will also confer as to the format for presenting issues that require additional explanation. When these are necessary, they should also be filed 3 business days before the conference. 3. Stay of responsive pleading obligations: The Court continues the stay of responsive pleading obligations provided for in Section 6(b) of the Court's initial order. 4. Pending motions: The Court DENIES WITHOUT PREJUDICE all pending motions in the individual cases comprising the MDL. These cases are also ADMINISTRATIVELY CLOSED. These terminated motions will later be refiled in accordance with an upcoming Case Management Order. 5. Docketing: All parties are to docket future filings only in the MDL case. The case caption should indicate whether any filing applies to all cases or list the individual cases to which it should apply. 6. Electronic service: The Court ORDERS all attorneys participating in the MDL proceeding to register with the Court's CM/ECF system. Because all attorneys will then receive electronic copies of documents filed in the MDL, the Court ORDERS that electronic service of documents via the Court's CM/ECF system satisfies the obligation of service. Hereafter, unless otherwise ordered, neither the clerk's office nor counsel for the parties shall be obligated to provide service copies of any filings or related orders by U.S. Mail or any other means to attorneys who have not registered with the Court's CM/ECF system. An attorney who is not participating in the MDL and does not want to receive CM/ECF notifications may file a motion to withdraw or a certificate of consent to withdraw in accordance with Local Rule 83.1(E). 7. Initial disclosures: The Court GRANTS the parties' joint request for the Court to excuse the parties from Rule 26(f) initial disclosures; except as to the ParaGard New Drug Application (NDA) that was transferred on or about November 10, 2005, to Duramed Pharmaceuticals, Inc., and produced by TWH, Inc., to plaintiff in the Estrada case. 8. Case management and initial orders: The parties are ORDERED to confer as to proposed orders for the list found herein. See order for further specifics and instructions. Signed by Judge Leigh Martin May on 2/10/2021.(tmf)
|
|
Filing 12
ELEVENTH AMENDMENT TO GENERAL ORDER 20-01 RE: COURT OPERATIONS UNDER THE EXIGENT CIRCUMSTANCES CREATED BY COVID-19 AND RELATED CORONAVIRUS. Signed by Judge Thomas W. Thrash, Jr. on 3/09/21. (aar)
|
| Filing 11 Case transferred in from District of New York Northern; Case Number 5:21-cv-00393. Original file certified copy of transfer order and docket sheet received. |
| Filing 10 JPMDL Conditional Transfer Order #16. Opposition period has expired with no objections filed. ORDER TRANSFERRING CASE to Northern District of Georgia for inclusion into MDL-2974 Paragard IUD Products Liability Litigation. Case to be assigned to the Hon. Leigh Martin May, U.S. District Judge. (plp) [Transferred from New York Northern on 4/26/2021.] |
| Civil Case Terminated. (tmf) |
| Filing 9 SUMMONS Returned Executed by Samantha Jonza. The Cooper Companies, Inc. served on 4/14/2021, answer due 5/5/2021. (Kassan, Randi) [Transferred from New York Northern on 4/26/2021.] |
| Filing 8 SUMMONS Returned Executed by Samantha Jonza. Teva Women's Health, LLC served on 4/14/2021, answer due 5/5/2021. (Kassan, Randi) [Transferred from New York Northern on 4/26/2021.] |
| Filing 7 SUMMONS Returned Executed by Samantha Jonza. Teva Pharmaceuticals USA, Inc. served on 4/14/2021, answer due 5/5/2021. (Kassan, Randi) [Transferred from New York Northern on 4/26/2021.] |
| Filing 6 SUMMONS Returned Executed by Samantha Jonza. Teva Women's Health, Inc. served on 4/14/2021, answer due 5/5/2021. (Kassan, Randi) [Transferred from New York Northern on 4/26/2021.] |
| Filing 5 SUMMONS Returned Executed by Samantha Jonza. Teva Branded Pharmaceutical Products R&D, Inc. served on 4/14/2021, answer due 5/5/2021. (Kassan, Randi) [Transferred from New York Northern on 4/26/2021.] |
| Filing 4 SUMMONS Returned Executed by Samantha Jonza. CooperSurgical, Inc. served on 4/14/2021, answer due 5/5/2021. (Kassan, Randi) [Transferred from New York Northern on 4/26/2021.] |
| Filing 3 G.O. 25 FILING ORDER ISSUED: Initial Rule 16 Conference by Telephone set for 7/14/2021 at 2:30 PM before Magistrate Judge Miroslav Lovric. Civil Case Management Plan must be filed and Mandatory Disclosures are to be exchanged by the parties on or before 7/7/2021. (Pursuant to Local Rule 26.2, mandatory disclosures are to be exchanged among the parties but are NOT to be filed with the Court.) (map) [Transferred from New York Northern on 4/26/2021.] |
| Filing 2 Summons Issued as to CooperSurgical, Inc., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc., Teva Women's Health, Inc., Teva Women's Health, LLC, The Cooper Companies, Inc.. (Attachments: #1 Summons Issued for Teva Women's Health, Inc. d/b/a Teva Women's Health LLC, #2 Summons Issued for Teva Women's Health, LLC, #3 Summons Issued for Teva Branded Pharmaceutical Products R&D, Inc., #4 Summons Issued for The Cooper Companies, Inc., #5 Summons Issued for CooperSurgical, Inc.)(map) [Transferred from New York Northern on 4/26/2021.] |
| Filing 1 COMPLAINT WITH JURY DEMAND against CooperSurgical, Inc., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc., Teva Women's Health, Inc., Teva Women's Health, LLC, The Cooper Companies, Inc. (Filing fee $402 receipt number ANYNDC-5485182) filed by Samantha Jonza. (Attachments: #1 Civil Cover Sheet)(map) [Transferred from New York Northern on 4/26/2021.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Georgia Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
